These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18159146)

  • 1. [Review: clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis].
    Kim HJ
    Korean J Hepatol; 2007 Dec; 13(4):489-94. PubMed ID: 18159146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis].
    Park JI; Choi KM; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Chung YH; Lee YS; Suh DJ
    Korean J Hepatol; 2007 Dec; 13(4):543-55. PubMed ID: 18159152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral treatment in liver cirrhosis due to hepatitis C virus].
    Martínez-Bauer E; Forns X
    Gastroenterol Hepatol; 2003 May; 26(5):303-6. PubMed ID: 12732104
    [No Abstract]   [Full Text] [Related]  

  • 4. Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case.
    Fukuhara T; Morita K; Takeishi K; Toshima T; Umeda K; Nagata S; Sugimachi K; Ikegami T; Gion T; Soejima Y; Taketomi A; Maehara Y
    Surg Today; 2010 Oct; 40(10):982-5. PubMed ID: 20872205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of chronic Hepatitis C in 2008].
    Niederau C; Kaden T
    MMW Fortschr Med; 2008 Mar; 150(13):31-4. PubMed ID: 18522354
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent hepatitis C virus infection and outcome after living-donor liver transplant.
    Satapathy SK; Fiel MI; Vanatta JM; Del Rio Martin J; Schiano TD
    Exp Clin Transplant; 2013 Dec; 11(6):522-9. PubMed ID: 23901801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
    Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.
    Honda M; Takehana K; Sakai A; Tagata Y; Shirasaki T; Nishitani S; Muramatsu T; Yamashita T; Nakamoto Y; Mizukoshi E; Sakai Y; Yamashita T; Nakamura M; Shimakami T; Yi M; Lemon SM; Suzuki T; Wakita T; Kaneko S;
    Gastroenterology; 2011 Jul; 141(1):128-40, 140.e1-2. PubMed ID: 21458454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of chronic hepatitis C].
    Schaffstein S; Rampini SK; Müllhaupt B
    Praxis (Bern 1994); 2014 Apr; 103(8):423-36. PubMed ID: 24713377
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of double filtration plasmapheresis with pegylated interferon/ribavirin therapy for intractable chronic hepatitis C patients and hepatitis C patients with combined liver cirrhosis by HBV, leading to early viral elimination.
    Ohara T; Oteki T; Suzuki T; Suzuki M; Matsuzaki Y
    Hepatogastroenterology; 2011; 58(105):133-6. PubMed ID: 21510300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of hepatitis C virus recurrence after living donor liver transplantation: Mansoura experience.
    Abdel-Wahab M; Abdel-Khalek EE; El-Gilany AH; Yassen AM; Al-Shobari M; Shiha U; Ali M; Sadani M; Salah T; Sultan AM; Elghawalby AN; Elmorshedi M; Al-Refaey AK; Abdalla U
    Arab J Gastroenterol; 2017 Sep; 18(3):151-155. PubMed ID: 28958486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living donor liver transplantation to patients with hepatitis C virus cirrhosis.
    Sugawara Y; Makuuchi M
    World J Gastroenterol; 2006 Jul; 12(28):4461-5. PubMed ID: 16874855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.
    Fukuhara T; Taketomi A; Motomura T; Okano S; Ninomiya A; Abe T; Uchiyama H; Soejima Y; Shirabe K; Matsuura Y; Maehara Y
    Gastroenterology; 2010 Nov; 139(5):1577-85, 1585.e1-3. PubMed ID: 20708617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SASLT practice guidelines: management of hepatitis C virus infection.
    Alghamdi AS; Sanai FM; Ismail M; Alghamdi H; Alswat K; Alqutub A; Altraif I; Shah H; Alfaleh FZ;
    Saudi J Gastroenterol; 2012 Sep; 18 Suppl(Suppl 1):S1-32. PubMed ID: 23006491
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin.
    Biermer M; Berg T
    Gastroenterology; 2009 Jul; 137(1):390-1. PubMed ID: 19486953
    [No Abstract]   [Full Text] [Related]  

  • 16. PEG-IFN and ribavirin re-treatment of HCV-1b cirrhosis non responder to conventional combination therapy.
    Morisco F; Amoruso D; Stroffolini T; Caporaso N
    Dig Liver Dis; 2008 May; 40(5):391-2. PubMed ID: 18291731
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot study.
    Tanaka T; Sugawara Y; Akamatsu N; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Kurosaki M; Izumi N; Kokudo N
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):144-50. PubMed ID: 25338946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis C virus infection.
    Flamm SL
    JAMA; 2003 May; 289(18):2413-7. PubMed ID: 12746366
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.
    Kawaoka T; Takahashi S; Takaki S; Hiramatsu A; Waki K; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Aikata H; Ochi H; Onoe T; Tashiro H; Ohdan H; Chayama K
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1467-72. PubMed ID: 22432893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyria cutanea tarda in an HCV-positive liver transplant patient: a case report.
    Pellicelli AM; Morrone A; Barbieri L; Andreoli A
    Ann Hepatol; 2012; 11(6):951-4. PubMed ID: 23109461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.